Not available
Quote | Kitov Pharma Ltd. (NASDAQ:KTOV)
Last: | $4.17 |
---|---|
Change Percent: | 2.21% |
Open: | $4.07 |
Close: | $4.17 |
High: | $4.19 |
Low: | $4.011 |
Volume: | 319,623 |
Last Trade Date Time: | 12/21/2020 04:56:12 pm |
News | Kitov Pharma Ltd. (NASDAQ:KTOV)
REHOVOT, Israel, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the Purple Biotech manageme...
Virtual Bell-Ringing Ceremony in Celebration of Company’s Recent Name Change to Purple Biotech REHOVOT, Israel, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class thera...
Message Board Posts | Kitov Pharma Ltd. (NASDAQ:KTOV)
Subject | By | Source | When |
---|---|---|---|
And GONE! | fwb | investorshub | 02/21/2021 3:14:31 PM |
Has our day come? Stay tuned..... | BJ_Cooper | investorshub | 02/09/2021 1:50:18 PM |
Great info...thank you... | georgie18 | investorshub | 02/09/2021 10:04:07 AM |
Vol over 10 MILLION today | fwb | investorshub | 02/08/2021 10:27:35 PM |
Morgan Stanley Bought in | fwb | investorshub | 02/08/2021 10:00:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Kitov Pharma Ltd. Company Name:
KTOV Stock Symbol:
NASDAQ Market:
REHOVOT, Israel, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the Purple Biotech manageme...
Virtual Bell-Ringing Ceremony in Celebration of Company’s Recent Name Change to Purple Biotech REHOVOT, Israel, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class thera...
New Name Reflects Company’s Evolution to Advancing First-in-Class Oncology Therapies TEL AVIV, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (the “Company”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to o...